GSK Pharma reports 35 per cent YoY rise in Q4FY25 profit led by gains in general medicines and vaccines; oncology launches ...

Glaxosmithkline Pharmaceutical advanced 3.21% to Rs 2,879.70 after the company's standalone net profit jumped 34.73% to Rs 260.14 crore on a 6.06% increase in revenue from operations to Rs 966.08 ...

GlaxoSmithKline Pharmaceuticals Ltd. reported a 36% increase in consolidated net profit to Rs 263 crore for the quarter ended ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

GlaxoSmithKline Pharmaceuticals reported a 36% rise in consolidated net profit to Rs 263 crore in the March quarter, driven by strong growth in its diversified portfolio. Revenue also increased to Rs ...

GlaxoSmithKline Pharmaceuticals on Tuesday said its consolidated net profit increased 36 per cent to Rs 263 crore during the March quarter. The company rep ...

Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, ...

Dr. Elizabeth Tarsi considers it a win when women visit her medical practice and seem comfortable talking about things they once may have considered embarrassing. Tarsi, a graduate of State University ...

Teal Health has made an at-home test that screens for human papillomavirus (HPV), the virus that causes nearly all cervical cancers.

The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

The US Food and Drug Administration (FDA) recently approved a first of its kind use-at-home cervical cancer screening tool.